Learn if your home or office potentially has mold, and discover if you have the common symptoms of mold exposure. Take our 3 min science-backed test for personalized results.
Take The Mold Quiz
Receive access to our specialized mold lab tests and clinically-supported prescription treatments, including binders, biofilm disruptors & our patented peptide. Launching 2025.
Unlock $5 MoldCo Consultation
We offer flexible and transparent pricing
Once the initial consultation is done, the average price per patient ranges from $200 to $300 per month, depending on the patient, and includes comprehensive treatment and care. Most patients complete their treatment within 3 to 6 months.
$5
Initial consultation fee with a MoldCo clinician after early-access discount.
$200
Estimated monthly pricing, based on popular treatment for Mold Illness.
Receive evidence-based specialized care
Our clinicians deliver curated treatments designed to eradicate harmful microbes, reduce inflammation, bind toxins, and restore metabolic health.
Claim Your Waitlist Spot
Not sure where to start?
Sign up to get priority access to our Mold certified clinicians when we launch. Our digital mold care platform is designed to address the root causes of your symptoms, providing you with clinically-supported solutions and ongoing support specific to mold exposure recovery.
Get a $5 Mold Illness consultation
Frequently Asked Questions
DISCLAIMER
Any health-related claims made on this site have not been evaluated by the Food and Drug Administration (FDA). The information provided on this site is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. MoldCo assumes no responsibility or liability for any errors or omissions in the content of the references, nor for any actions taken in reliance thereon.
The clinical studies referenced are intended to support the use of health products and treatments related to biotoxin-driven morbidity and Mold Illness. These studies are not reflective of ongoing investigational drug development efforts. The information provided is based on existing research and is meant to inform healthcare professionals and patients about potential treatment options for biotoxin-related health conditions and indoor environmental exposures to biotoxins. It is important to consult with a qualified healthcare provider before starting any new treatment regimen. All medical protocols and studies implied as guiding our products that address Mold Illness are subject to evaluation by a licensed medical professional qualified to assess individual eligibility for treatment.